Search research articles
Contact Us
Filters
Showing results (181-190 of 194) with videos related to
Page
of 20
Sort By:
Frontiers in Immunology
|
April 4, 2022
Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy
Jingxian Gu, Sining Liu, Wei Cui, et al.
Scientific Reports
|
January 11, 2022
The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients
Minghao Li, Sheng-Li Xue, Xiaowen Tang, et al.
Frontiers in Immunology
|
March 19, 2026
Quantitative evaluation of T-cell repertoire restoration following hematopoietic stem cell transplantation in patients with and without graft versus host disease
Xin Zhang, Pengyi Song, Longhai Tang, et al.
Blood
|
March 18, 2026
Randomized trial of GvHD Prophylaxis in Haploidentical PBSC Transplantation: ATG, PTCy, and Low-Dose Combination Therapy
Jun Yang, Yannan Jia, Xiaoxia Hu, et al.
Blood Science (Baltimore, Md.)
|
June 24, 2024
Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry study
Mingyuan Sun, Qingsong Yin, Yang Liang, et al.
Leukemia & Lymphoma
|
March 13, 2024
Comparison of valganciclovir <i>versus</i> foscarnet for the treatment of cytomegalovirus viremia in adult acute leukemia patients after allogeneic hematopoietic cell transplantation
Jinjin Zhu, Mimi Xu, Yuhua Ru, et al.
Discover Oncology
|
February 21, 2025
Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVAD
Jing Lu, Yu Zhu, Huiying Qiu, et al.
Blood Cancer Journal
|
April 24, 2023
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?
Sining Liu, Xinyue Zhang, Haiping Dai, et al.
Journal of Hematology & Oncology
|
September 1, 2024
Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial
Jing Lu, Huiying Qiu, Ying Wang, et al.
Haematologica
|
November 27, 2025
Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter study
Mingkai Shu, Wenjing Ding, Linlin Wang, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 194) with videos related to
Sort By:
Page
of 20
Frontiers in Immunology
|
April 4, 2022
Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy
Jingxian Gu, Sining Liu, Wei Cui, et al.
Scientific Reports
|
January 11, 2022
The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients
Minghao Li, Sheng-Li Xue, Xiaowen Tang, et al.
Frontiers in Immunology
|
March 19, 2026
Quantitative evaluation of T-cell repertoire restoration following hematopoietic stem cell transplantation in patients with and without graft versus host disease
Xin Zhang, Pengyi Song, Longhai Tang, et al.
Blood
|
March 18, 2026
Randomized trial of GvHD Prophylaxis in Haploidentical PBSC Transplantation: ATG, PTCy, and Low-Dose Combination Therapy
Jun Yang, Yannan Jia, Xiaoxia Hu, et al.
Blood Science (Baltimore, Md.)
|
June 24, 2024
Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry study
Mingyuan Sun, Qingsong Yin, Yang Liang, et al.
Leukemia & Lymphoma
|
March 13, 2024
Comparison of valganciclovir <i>versus</i> foscarnet for the treatment of cytomegalovirus viremia in adult acute leukemia patients after allogeneic hematopoietic cell transplantation
Jinjin Zhu, Mimi Xu, Yuhua Ru, et al.
Discover Oncology
|
February 21, 2025
Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVAD
Jing Lu, Yu Zhu, Huiying Qiu, et al.
Blood Cancer Journal
|
April 24, 2023
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?
Sining Liu, Xinyue Zhang, Haiping Dai, et al.
Journal of Hematology & Oncology
|
September 1, 2024
Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial
Jing Lu, Huiying Qiu, Ying Wang, et al.
Haematologica
|
November 27, 2025
Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter study
Mingkai Shu, Wenjing Ding, Linlin Wang, et al.
Page
of 20